Anja Garritsen | CEO & Founder, Innatoss Laboratories
Innatoss Laboratories, founded in 2012, specializes in infectious diseases with long term consequences: Lyme disease, Q fever, and COVID-19. Development of novel test paradigms for Lyme disease resulted in an ongoing nation-wide screening programme for Lyme Disease with 150 participating organizations and over 5000 participants. Being in the middle of the Q fever epidemic region resulted in a novel Q-fever test, but also in an 8-year long collaboration with Mass General Hospital (Boston) and Australian labs and universities. During the COVID-19 pandemic its diagnostic focus changed quickly from measuring immune responses to testing for virus and understanding how vaccination and infections protect against new infections. As an independent, accredited, diagnostic laboratory, Innatoss runs its own diagnostic and research programmes but also helps diagnostics companies to validate new tests.
Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | |
|
© Copyright 2020 by Hyphen Projects